[2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate

C115H89F3N20O14S7 — CID 158439649

About [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate

[2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate (PubChem CID 158439649) has the molecular formula C115H89F3N20O14S7 and a molecular weight of 2256.57 g/mol. Its IUPAC name is [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate.

Molecular Properties

• Compound Name: [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate
• PubChem CID: 158439649
• Molecular Formula: C115H89F3N20O14S7
• Molecular Weight: 2256.57 g/mol
• Exact Mass: 2254.49
• IUPAC Name: [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate
• SMILES: O=COc1csc(-n2nc(-c3ccccc3)c3ccc(NCc4ccc(F)cc4)cc32)n1.O=COc1csc(-n2nc(-c3ccccc3)c3ccc(NCc4cccc(F)c4)cc32)n1.O=COc1csc(-n2nc(-c3ccccc3)c3ccc(NCc4ccccc4F)cc32)n1.O=COc1csc(-n2nc(-c3ccccc3)c3ccc(NS(=O)(=O)C4CC4)cc32)n1.O=COc1csc(-n2nc(-c3ccccc3)c3ccc(NS(=O)(=O)C4CCCCC4)cc32)n1
• InChI: InChI=1S/3C24H17FN4O2S.C23H22N4O4S2.C20H16N4O4S2/c25-18-8-4-5-16(11-18)13-26-19-9-10-20-21(12-19)29(24-27-22(14-32-24)31-15-30)28-23(20)17-6-2-1-3-7-17;25-20-9-5-4-8-17(20)13-26-18-10-11-19-21(12-18)29(24-27-22(14-32-24)31-15-30)28-23(19)16-6-2-1-3-7-16;25-18-8-6-16(7-9-18)13-26-19-10-11-20-21(12-19)29(24-27-22(14-32-24)31-15-30)28-23(20)17-4-2-1-3-5-17;28-15-31-21-14-32-23(24-21)27-20-13-17(26-33(29,30)18-9-5-2-6-10-18)11-12-19(20)22(25-27)16-7-3-1-4-8-16;25-12-28-18-11-29-20(21-18)24-17-10-14(23-30(26,27)15-7-8-15)6-9-16(17)19(22-24)13-4-2-1-3-5-13/h3*1-12,14-15,26H,13H2;1,3-4,7-8,11-15,18,26H,2,5-6,9-10H2;1-6,9-12,15,23H,7-8H2
• InChIKey: HCQQGGIGNHGNKA-UHFFFAOYSA-N
• XLogP: 24.65
• TPSA: 413.48 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 37
• Rotatable Bonds: 35
• Heavy Atoms: 159
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2256.57
LogP ≤ 5	24.65
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	37

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aldehyde', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate?

The IUPAC name of [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate (CID 158439649) is [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate.

What is the SMILES notation for [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate?

The canonical SMILES for [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate is O=COc1csc(-n2nc(-c3ccccc3)c3ccc(NCc4ccc(F)cc4)cc32)n1.O=COc1csc(-n2nc(-c3ccccc3)c3ccc(NCc4cccc(F)c4)cc32)n1.O=COc1csc(-n2nc(-c3ccccc3)c3ccc(NCc4ccccc4F)cc32)n1.O=COc1csc(-n2nc(-c3ccccc3)c3ccc(NS(=O)(=O)C4CC4)cc32)n1.O=COc1csc(-n2nc(-c3ccccc3)c3ccc(NS(=O)(=O)C4CCCCC4)cc32)n1.

What is the InChIKey of [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate?

The InChIKey is HCQQGGIGNHGNKA-UHFFFAOYSA-N. The full InChI is InChI=1S/3C24H17FN4O2S.C23H22N4O4S2.C20H16N4O4S2/c25-18-8-4-5-16(11-18)13-26-19-9-10-20-21(12-19)29(24-27-22(14-32-24)31-15-30)28-23(20)17-6-2-1-3-7-17;25-20-9-5-4-8-17(20)13-26-18-10-11-19-21(12-18)29(24-27-22(14-32-24)31-15-30)28-23(19)16-6-2-1-3-7-16;25-18-8-6-16(7-9-18)13-26-19-10-11-20-21(12-19)29(24-27-22(14-32-24)31-15-30)28-23(20)17-4-2-1-3-5-17;28-15-31-21-14-32-23(24-21)27-20-13-17(26-33(29,30)18-9-5-2-6-10-18)11-12-19(20)22(25-27)16-7-3-1-4-8-16;25-12-28-18-11-29-20(21-18)24-17-10-14(23-30(26,27)15-7-8-15)6-9-16(17)19(22-24)13-4-2-1-3-5-13/h3*1-12,14-15,26H,13H2;1,3-4,7-8,11-15,18,26H,2,5-6,9-10H2;1-6,9-12,15,23H,7-8H2.

What are the key properties of [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate?

[2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate has a molecular weight of 2256.57 g/mol, XLogP of 24.65, 35 rotatable bonds, 5 hydrogen bond donors, and 37 hydrogen bond acceptors.

Where does this data come from?

All data for [2-[6-(cyclohexylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-(cyclopropylsulfonylamino)-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(2-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(3-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[6-[(4-fluorophenyl)methylamino]-3-phenylindazol-1-yl]-1,3-thiazol-4-yl] formate is sourced from PubChem (CID 158439649), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).